Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 2
1995 3
1996 5
1997 4
1998 2
1999 3
2000 3
2001 6
2002 2
2003 4
2004 3
2005 3
2006 2
2007 3
2008 4
2009 4
2011 2
2012 3
2013 2
2014 4
2015 4
2016 2
2017 4
2018 4
2019 1
2020 3
2021 3
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. Among authors: lebtahi r. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: lebtahi r. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms.
Bourdeleau P, Couvelard A, Ronot M, Lebtahi R, Hentic O, Ruszniewski P, Cros J, de Mestier L. Bourdeleau P, et al. Among authors: lebtahi r. Ther Adv Med Oncol. 2023 Jun 9;15:17588359231179310. doi: 10.1177/17588359231179310. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37323185 Free PMC article. Review.
Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.
Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R. Deguelte S, et al. Among authors: lebtahi r. J Visc Surg. 2018 Dec;155(6):483-492. doi: 10.1016/j.jviscsurg.2018.08.010. Epub 2018 Nov 15. J Visc Surg. 2018. PMID: 30448206 Free article. Review.
Imaging inflammatory cardiomyopathies.
Le Guludec D, Sarda L, Rouzet F, Merlet P, Slama MS, Lebtahi R. Le Guludec D, et al. Among authors: lebtahi r. J Nucl Cardiol. 2005 Nov-Dec;12(6):731-9. doi: 10.1016/j.nuclcard.2005.09.005. J Nucl Cardiol. 2005. PMID: 16344235 Review. No abstract available.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.
Kwekkeboom DJ, Krenning EP, Scheidhauer K, Lewington V, Lebtahi R, Grossman A, Vitek P, Sundin A, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Kwekkeboom DJ, et al. Among authors: lebtahi r. Neuroendocrinology. 2009;90(2):184-9. doi: 10.1159/000225946. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713709 No abstract available.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
Kwekkeboom DJ, Krenning EP, Lebtahi R, Komminoth P, Kos-Kudła B, de Herder WW, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Kwekkeboom DJ, et al. Among authors: lebtahi r. Neuroendocrinology. 2009;90(2):220-6. doi: 10.1159/000225951. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713714
Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET.
Lugat A, Frampas É, Touchefeu Y, Mirallié É, Bras ML, Senellart H, Rauscher A, Fleury V, Campion L, Rohmer V, Couturier OF, Lebtahi R, Rouzet F, Ruszniewski P, Kraeber-Bodéré F, Bourgeois M, Ansquer C. Lugat A, et al. Among authors: lebtahi r. Cancers (Basel). 2023 Jan 14;15(2):513. doi: 10.3390/cancers15020513. Cancers (Basel). 2023. PMID: 36672462 Free PMC article.
87 results